Health insurance provider Elevance Health (NYSE: EVH) will be reporting results this Wednesday morning. Here’s what to look for.

Elevance Health missed analysts’ revenue expectations last quarter, reporting revenues of $49.31 billion, up 9.6% year on year. It was a softer quarter for the company, with a significant miss of analysts’ full-year EPS guidance estimates and a slight miss of analysts’ revenue estimates. It lost -137,000 customers and ended up with a total of 45.23 million.

Is Elevance Health a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, the market is expecting Elevance Health’s revenue to be flat year on year, slowing from the 15.4% increase it recorded in the same quarter last year.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Elevance Health has missed Wall Street’s revenue estimates multiple times over the last two years.

With Elevance Health being the first among its peers to report earnings this season, we don’t have anywhere else to look to get a hint at how this quarter will unravel for healthcare providers & services stocks. However, there has been positive investor sentiment in the segment, with share prices up 9% on average over the last month. Elevance Health is up 11% during the same time .

ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.

Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.